Global X S&P Biotech ETF(ASX) CURE

Market CapN/A

Since IPO (2018)+89%

5 Year+29%

1 Year+62%

1 Month-2%

A$73.22

-0.96%

-0.71Today

Global X S&P Biotech ETF last closing stock price
Metric	Price	Date
Last close	AUD 73.93	2026-07-27

Global X S&P Biotech ETF stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-1.37%	AUD 74.96	2026-07-20
1 month	-1.82%	AUD 75.30	2026-06-26
3 month	+17.85%	AUD 62.73	2026-04-28
Year to date	+19.24%	AUD 62.00	2025-12-31
1 year	+62.2%	AUD 45.58	2025-07-25
3 year	+76.49%	AUD 41.89	2023-07-28
5 year	+29.26%	AUD 57.19	2021-07-28
Since inception	+88.75%	AUD 39.17	2018-11-12

Global X S&P Biotech ETF Financials at a Glance

Market Cap

N/A

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

A$0.00

P/E Ratio

0.00

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Price

A$73.22

Volume

224

Open

A$73.77

Price

A$73.22

Volume

224

Open

A$73.77

Previous Close

A$73.22

Daily Range

A$72.83 - A$73.77

52-Week Range

A$43.92 - A$81.49

Estimated Earnings Date

N/A

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Price

A$73.22

Volume

224

Open

A$73.77

Previous Close

A$73.22

Daily Range

A$72.83 - A$73.77

52-Week Range

A$43.92 - A$81.49

Estimated Earnings Date

N/A

CURE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Global X S&P Biotech ETF

The Global X - S&P Biotech ETF aims to replicate the financial performance of the S&P Biotechnology Select Industry Index. This ETF focuses on capital gains and dividends, providing investors with exposure to the biotechnology sector.

Products and Services

Tracks the S&P Biotechnology Select Industry Index
Offers exposure to leading biotech companies
Designed for investors seeking sector-specific investments

Growth Outlook

Biotech sector projected to grow significantly in the coming years
Increased demand for innovative healthcare solutions drives growth
Technological advancements enhance biotech research and development

Financial Highlights

Market capitalization of AUD 40.21 million
Stock price range between AUD 43.92 and AUD 81.49
Recent trading volume of 320 shares

The Global X - S&P Biotech ETF provides a strategic investment opportunity in the biotechnology sector, which is poised for substantial growth. The ETF's focus on replicating the performance of a well-established index allows investors to gain exposure to a diverse range of biotech companies. With a solid market capitalization and a favorable stock price range, this ETF may appeal to those looking to invest in a dynamic and evolving industry. The ongoing advancements in biotechnology and the increasing demand for healthcare innovations further underscore the potential for growth in this sector.

AI Generated • Jul 17, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

Sydney, NSW 2000, AU

CURE Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

224

Avg. Volume

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Global X S&P Biotech ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

CurrentYOY CHG

Revenue

N/A

Gross Profit

N/A

Gross Margin

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

N/A

EBITDA

N/A

Quarterly Fundamentals

Name

CurrentYOY CHG

Total Cash

N/A

Total Debt

N/A

Accounts Receivable

N/A

Inventory

N/A

Long Term Debt

N/A

Short Term Debt

N/A

Return on Assets

N/A

Return on Invested Capital

N/A

Free Cash Flow

N/A

Operating Cash Flow

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HGEN.AXGlobal X Hydrogen ETF

HGEN.AXGlobal X Hydrogen ETFA$8.79-5.48%

CETF.AXVanEck - FTSE China A50 ETF

CETF.AXVanEck - FTSE China A50 ETFA$63.17-0.64%

MVOL.AXiShares Edge MSCI Australia Minimum Volatility ETF

MVOL.AXiShares Edge MSCI Australia Minimum Volatility ETFA$36.05+1.09%

SSO.AXState Street SPDR S&P/ASX Small Ordinaries ETF

SSO.AXState Street SPDR S&P/ASX Small Ordinaries ETFA$14.18+0.35%

OZF.AXState Street SPDR S&P/ASX 200 Financials EX A-REIT ETF

OZF.AXState Street SPDR S&P/ASX 200 Financials EX A-REIT ETFA$31.88+0.79%

BOND.AXState Street SPDR S&P/ASX iBoxx Australian Bond ETF

BOND.AXState Street SPDR S&P/ASX iBoxx Australian Bond ETFA$25.17+0.08%

VMIN.AXVanguard Global Minimum Volatility Active ETF

VMIN.AXVanguard Global Minimum Volatility Active ETFA$61.79+0.06%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$91.67-0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.25+0.10%

NOKNokia

NOKNokia$9.28+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.95+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.24-0.02%

TAT&T

TAT&T$24.42+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.40-0.01%

Questions About CURE

What is the current price of Global X S&P Biotech ETF?

Global X S&P Biotech ETF is trading at A$73.22 per share.

What is the 52-week range for Global X S&P Biotech ETF?

Over the past 52 weeks, Global X S&P Biotech ETF has traded between A$43.92 and A$81.49.

How much debt does Global X S&P Biotech ETF have?

Global X S&P Biotech ETF total debt is unavailable.

How much cash does Global X S&P Biotech ETF have on hand?

Global X S&P Biotech ETF does not have cash on hand data available.

What is Global X S&P Biotech ETF’s dividend yield?

Global X S&P Biotech ETF does not currently have a dividend yield.

Global X S&P Biotech ETF(ASX) CURE

Global X S&P Biotech ETF Financials at a Glance

CURE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Global X S&P Biotech ETF

CURE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Global X S&P Biotech ETF Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CURE

What is the current price of Global X S&P Biotech ETF?

What is the 52-week range for Global X S&P Biotech ETF?

How much debt does Global X S&P Biotech ETF have?

How much cash does Global X S&P Biotech ETF have on hand?

What is Global X S&P Biotech ETF’s dividend yield?

Premium Investing Services